Chardan Capital analyst Steven Wardell maintained a Buy rating on Tivity Health Inc (TVTY) today and set a price target of $24. The company’s shares closed last Monday at $18.78, close to its 52-week low of $14.84.
Wardell said:
“We like the company’s continuing momentum in the healthcare business and successful selling season in Prime Fitness business. We liked Management’s confidence around addressing the Nutrisystem issues. We maintain our Buy rating and lower our 12-month $24 based on lower estimates and the company’s lower trading multiple.”
According to TipRanks.com, Wardell is a 4-star analyst with an average return of 16.8% and a 51.4% success rate. Wardell covers the Technology sector, focusing on stocks such as Benefitfocus, Phreesia Inc, and Model N.
Currently, the analyst consensus on Tivity Health Inc is a Moderate Buy with an average price target of $32.50, a 73.1% upside from current levels. In a report issued on August 8, Barrington also maintained a Buy rating on the stock with a $40 price target.
See today’s analyst top recommended stocks >>
Tivity Health Inc’s market cap is currently $898.3M and has a P/E ratio of 10.84. The company has a Price to Book ratio of 1.70.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tivity Health, Inc. engages in the development and provision of network solutions and health management services. It offers rehabilitative therapy, chiropractic procedure, alternative medicines, and health and fitness programs under the SilverSneakers, Prime Fitness, and WholeHealth Living trademarks.
